Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04575961
Title Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer (PERCEPTION)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.